The immunohistochemical analysis of PD-L1 expression in the samples of patients with surgically resected NSCLC also showed that EGFR mutation and adenocarcinoma were independent factors of increased PD-L1 expression (Azuma et al., 2014). This evidence concerns the gene CD274 and non-small cell lung carcinoma.